Outsourcing Facilities: Registration and reporting of drugs under 503B(b)

Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act

21 USC 353b Sec 503B FFDCA OCT 2022

Outsourcing Facilities: Registration and reporting of drugs under 503B(b)

OMB: 0910-0800